Cargando…
A cytotoxic DNA precursor is taken up selectively by human cancer xenografts.
Autores principales: | Bagshawe, K. D., Boden, J., Boxer, G. M., Britton, D. W., Green, A., Partridge, T., Pedley, B., Sharma, S., Southall, P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001750/ https://www.ncbi.nlm.nih.gov/pubmed/3567064 |
Ejemplares similares
-
The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.
por: Pedley, R. B., et al.
Publicado: (1989) -
Preliminary observations on the microdistribution of labelled antibodies in human colonic adenocarcinoma xenografts: relevance to microdosimetry.
por: Pedley, R. B., et al.
Publicado: (1990) -
Dose-dependent localisation and potential for therapy of F(ab')2 fragments against CEA studied in a human tumour xenograft model.
por: Rogers, G. T., et al.
Publicado: (1986) -
Prolonged localisation of a monoclonal antibody against CEA in a human colon tumour xenograft.
por: Harwood, P. J., et al.
Publicado: (1985) -
A human choriocarcinoma xenograft in nude mice; a model for the study of antibody localization.
por: Searle, F., et al.
Publicado: (1981)